State Street
CLPT icon

State Street’s ClearPoint Neuro CLPT Stock Holding History

State Street’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.19M Buy
679,819
+51,758
+8% +$654K ﹤0.01% 2852
2025
Q4 		$8.59M Buy
628,061
+145,411
+30% +$2.7M ﹤0.01% 2720
2025
Q3 		$10.5M Buy
482,650
+149,269
+45% +$1.76M ﹤0.01% 2610
2025
Q2 		$3.98M Buy
333,381
+207,533
+165% +$2.61M ﹤0.01% 3039
2025
Q1 		$1.5M Buy
125,848
+9,600
+8% +$149K ﹤0.01% 3339
2024
Q4 		$1.79M Buy
116,248
+11,046
+10% +$143K ﹤0.01% 3352
2024
Q3 		$1.18M Sell
105,202
-24,300
-19% -$233K ﹤0.01% 3459
2024
Q2 		$698K Sell
129,502
-286,774
-69% -$1.66M ﹤0.01% 3526
2024
Q1 		$2.83M Buy
416,276
+67,378
+19% +$471K ﹤0.01% 3163
2023
Q4 		$2.37M Buy
348,898
+21,684
+7% +$123K ﹤0.01% 3257
2023
Q3 		$1.64M Buy
327,214
+19,900
+6% +$118K ﹤0.01% 3404
2023
Q2 		$2.22M Buy
307,314
+238,412
+346% +$2.03M ﹤0.01% 3356
2023
Q1 		$582K Buy
68,902
+2,700
+4% +$23.7K ﹤0.01% 3692
2022
Q4 		$561K Buy
66,202
+10,100
+18% +$95.7K ﹤0.01% 3729
2022
Q3 		$581K Buy
56,102
+300
+0.5% +$3.95K ﹤0.01% 3723
2022
Q2 		$728K Sell
55,802
-247,533
-82% -$2.53M ﹤0.01% 3703
2022
Q1 		$3.16M Buy
303,335
+2,125
+0.7% +$19.3K ﹤0.01% 3392
2021
Q4 		$3.38M Sell
301,210
-9,661
-3% -$145K ﹤0.01% 3434
2021
Q3 		$5.52M Buy
310,871
+36,822
+13% +$691K ﹤0.01% 3186
2021
Q2 		$5.23M Buy
+274,049
New +$5.3M ﹤0.01% 3226

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street's CLPT Position: Q1 2026 in Review

State Street increased its ClearPoint Neuro (CLPT) stake by 8.2% in Q1 2026, buying an estimated $654K and bringing the position to 679,819 shares worth $6.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2852.

State Street first reported a position in CLPT in Q2 2021 and has held it in 20 quarters since. The position peaked at $10.5M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • State Street held 679,819 shares of ClearPoint Neuro worth $6.19M as of Q1 2026.
  • State Street bought 51,758 ClearPoint Neuro shares in Q1 2026, an estimated $654K.
  • ClearPoint Neuro made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2852 holding.
  • State Street first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 20 quarters since.
  • State Street's ClearPoint Neuro position peaked at $10.5M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.